Sally is a Programme Leader and senior statistician in the Cancer and Other Non-Infectious Diseases research theme at the CTU, and Professor of Medical Statistics at University College London.
She joined the MRC in 1986 as a statistician in the Cancer Trials Office, then based within the Clinical Oncology and Radiotherapeutics Unit in Cambridge, before joining the CTU in London in 1999. She has worked in many cancer sites including brain, gastric, oesophageal, colorectal and ovarian cancer, and lymphoma, with a particularly enduring interest in the design, conduct and analysis of clinical trials and related research in testicular cancer. This included being the lead statistician developing the International Germ Cell Consensus Classification and many practice-changing trials.
Sally is also a core member of the London Hub for Trial Methodology Research, and is co-lead with Sarah Meredith of our work in trial conduct methodology, a new area of research which aims to improve the evidence base for trial conduct.
Bakobaki J, Rauchenberger M, Joffe N, McCormack S, Stenning S and Meredith S. The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial. Clinical Trials 2012;9(2):257-64.
GM Mead, SD Fossa, RTD Oliver, JK Joffe, RA Huddart, JT Roberts, P Pollock, R Gabe and SP Stenning for the MRC and EORTC seminoma trial collaborators. Mature results of three randomised Medical Research Council (MRC) trials (TE10,18 and 19) in 2466 patients with stage I seminoma: Survival, patterns of relapse and follow up. JNCI 2011, 103(3):241-9.
WH Allum, SP Stenning, J Bancewicz, PI Clark and RE Langley (2009). Long Term Results of MRC OEO2 a Randomised Trial of Surgery with or without Preoperative Chemotherapy in Oesophageal Cancer. J Clin Oncol 27:5062-5067, 2009.
Cunningham D, Allum WH, Stenning SP et al (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006 Jul 6;355(1):11-20.
Cullen MH and Stenning SP (2004). Clinical trials with moving targets: a commentary on an equivalence trial in testicular cancer. Lancet Oncology 5: 129-132.